Skip to main content
SpringerLink

Collagen-Induced Arthritis in Mice

A Major Role for Tumor Necrosis Factor-α

  • Protocol
Target Discovery and Validation Reviews and Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 361))

Abstract

Collagen-induced arthritis is the most widely used animal model for the evaluation of novel therapeutic strategies for rheumatoid arthritis. The disease is induced by immunization of genetically susceptible strains of mice or rats with type II collagen in adjuvant. Susceptibility to collagen-induced arthritis is associated with major histocompatibility complex (MHC) class II genes, although non-MHC genes also play a role. Both B- and T-lymphocytes are important in the pathogenesis of collagen-induced arthritis, with the peak of the T-cell response occurring around the time of disease onset. Histopathological assessment of the joints of animals with collagen-induced arthritis reveal a proliferative synovitis with infiltration of polymorphonuclear and mononuclear cells, the formation of an erosive pannus, cartilage degradation, and fibrosis. As in human rheumatoid arthritis, a number of both pro- and anti-inflammatory cytokines are expressed in the joints of mice with collagen-induced arthritis, including tumor necrosis factor-α (TNFα) and interleukin (IL)-1β, IL-6, IL-1Ra, IL-10, and transforming growth factor β. The use transgenic and knockout strains of mice, as well as biological inhibitors, have revealed important pathological roles for multiple cytokines. Of these, TNFα emerged as a valid therapeutic target for rheumatoid arthritis and this led to the setting up of clinical trials of anti-TNFα antibody therapy. Three anti-TNFα biologics (infliximab, etanercept, and adalimumab) are now approved for use and TNFα blockade therefore represents an important advance in our ability to treat rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Elliott, M. J., Maini, R. N., Feldmann, M., et al. (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum. 36, 1681–1690.

    Article  CAS  PubMed  Google Scholar 

  2. Elliott, M. J., Maini, R. N., Feldmann, M., et al. (1994) Treatment with a chimeric monoclonal antibody to tumour necrosis factor α suppresses disease activity in rheumatoid arthritis: results of a multi-centre, randomised, double blind trial. Lancet 344, 1105–1110.

    Article  CAS  PubMed  Google Scholar 

  3. Elliott, M. J., Maini, R. N., Feldmann, M., et al. (1994) Repeated therapy with a monoclonal antibody to tumour necrosis factor α in patients with rheumatoid arthritis. Lancet 344, 1125–1127.

    Article  CAS  PubMed  Google Scholar 

  4. Moreland, L. W., Baumgartner, S. W., Schiff, M. H., et al. (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337, 141–147.

    Article  CAS  PubMed  Google Scholar 

  5. Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., et al. (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340, 253–259.

    Article  CAS  PubMed  Google Scholar 

  6. Kempeni, J. (1999) Preliminary results of early clinical trials with the fully human anti-TNF monoclonal antibody D2E7. Ann. Rheum. Dis. 58, I70–I72.

    Article  CAS  PubMed  Google Scholar 

  7. den Broeder, A., van de Putte, L., Rau, R., et al. (2002) A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis. J. Rheumatol. 29, 2288–2298.

    Google Scholar 

  8. Weinblatt, M. E., Keystone, E. C., Furst, D. E., et al. (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 48, 35–45.

    Article  CAS  PubMed  Google Scholar 

  9. Williams, R. O. (1998) Rodent models of arthritis: relevance for human disease. Clin. Exp. Immunol. 114, 330–332.

    Article  CAS  PubMed  Google Scholar 

  10. Ranges, G. E., Sriram, S., and Cooper, S. M. (1985) Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162, 1105–1110.

    Article  CAS  PubMed  Google Scholar 

  11. Hom, J. T., Butler, L. D., Riedl, P. E., and Bendele, A. M. (1988) The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities. Eur. J. Immunol. 18, 881–888.

    Article  CAS  PubMed  Google Scholar 

  12. Webb, L. M., Walmsley, M. J., and Feldmann, M. (1996) Prevention and amelioratrion of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur. J. Immunol. 26, 2320–2328.

    Article  CAS  PubMed  Google Scholar 

  13. Malfait, A.-M., Butler, D. M., Presky, D. H., Maini, R. N., Brennan, F. M., and Feldmann, M. (1998) Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin. Exp. Immunol. 111, 377–383.

    Article  CAS  PubMed  Google Scholar 

  14. Holmdahl, R., Andersson, M. E., Goldschmidt, T. J., et al. (1989) Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 97, 575–584.

    Article  CAS  PubMed  Google Scholar 

  15. Trentham, D. E. (1982) Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con. Arthritis Rheum. 25, 911–916.

    Article  CAS  PubMed  Google Scholar 

  16. Williams, R. O., Williams, D. G., and Maini, R. N. (1992) Anti-type II collagen ELISA. Increased disease specificity following removal of anionic contaminants from salt-fractionated type II collagen. J. Immunol. Methods 147, 93–100.

    CAS  PubMed  Google Scholar 

  17. Marinova-Mutafchieva, L., Williams, R. O., Mason, L. J., Mauri, C., Feldmann, M., and Maini, R. N. (1997) Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107, 507–512.

    Article  CAS  PubMed  Google Scholar 

  18. Hegen, M., Sun, L., Uozumi, N., et al. (2003) Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J. Exp. Med. 197, 1297–1302.

    Article  CAS  PubMed  Google Scholar 

  19. Holmdahl, R., Jansson, L., Larsson, E., Rubin, K., and Klareskog, L. (1986) Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum. 29, 106–113.

    Article  CAS  PubMed  Google Scholar 

  20. Boissier, M. C., Feng, X. Z., Carlioz, A., Roudier, R., and Fournier, C. (1987) Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann. Rheum. Dis. 46, 691–700.

    Article  CAS  PubMed  Google Scholar 

  21. Malfait, A. M., Williams, R. O., Malik, A. S., Maini, R. N., and Feldmann, M. (2001) Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. Arthritis Rheum. 44, 1215–1224.

    Article  CAS  PubMed  Google Scholar 

  22. Huang, J. C., Vestberg, M., Minguela, A., Holmdahl, R., and Ward, E. S. (2004) Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers. Int. Immunol. 16, 283–293.

    Article  CAS  PubMed  Google Scholar 

  23. Keffer, J., Probert, L., Cazlaris, H., et al. (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025–4031.

    CAS  PubMed  Google Scholar 

  24. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., and Kollias, G. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387–398.

    Article  CAS  PubMed  Google Scholar 

  25. Probert, L., Plows, D., Kontogeorgos, G., and Kollias, G. (1995) The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur. J. Immunol. 25, 1794–1797.

    Article  CAS  PubMed  Google Scholar 

  26. Brennan, F. M., Chantry, D., Jackson, A., Maini, R., and Feldmann, M. (1989) Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244–247.

    Article  CAS  PubMed  Google Scholar 

  27. Niki, Y., Yamada, H., Seki, S., et al. (2001) Macrophage-and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice. J. Clin. Invest. 107, 1127–1135.

    Article  CAS  PubMed  Google Scholar 

  28. Fell, H. B. and Jubb, R. W. (1977) The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum. 20, 1359–1371.

    Article  CAS  PubMed  Google Scholar 

  29. Saklatvala, J., Pilsworth, L. M., Sarsfield, S. J., Gavrilovic, J., and Heath, J. K. (1984) Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem. J. 224, 461–466.

    CAS  PubMed  Google Scholar 

  30. Saklatvala, J., Sarsfield, S. J., and Townsend, Y. (1985) Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever. J. Exp. Med. 162, 1208–1222.

    Article  CAS  PubMed  Google Scholar 

  31. McIntyre, K. W., Shuster, D. J., Gillooly, K. M., et al. (1996) Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26, 2933–2938.

    Article  CAS  PubMed  Google Scholar 

  32. Wei, X. Q., Leung, B. P., Arthur, H. M., McInnes, I. B., and Liew, F. Y. (2001) Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J. Immunol. 166, 517–521.

    CAS  PubMed  Google Scholar 

  33. Plater-Zyberk, C., Joosten, L. A., Helsen, M. M., et al. (2001) Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108, 1825–1832.

    CAS  PubMed  Google Scholar 

  34. Alonzi, T., Fattori, E., Lazzaro, D., et al. (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187, 461–468.

    Article  CAS  PubMed  Google Scholar 

  35. Sasai, M., Saeki, Y., Ohshima, S., et al. (1999) Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum. 42, 1635–1643.

    Article  CAS  PubMed  Google Scholar 

  36. Takagi, N., Mihara, M., Moriya, Y., et al. (1998) Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum. 41, 2117–2121.

    Article  CAS  PubMed  Google Scholar 

  37. Mihara, M., Kotoh, M., Nishimoto, N., et al. (2001) Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin. Immunol. 98, 319–326.

    Article  CAS  PubMed  Google Scholar 

  38. Nakae, S., Nambu, A., Sudo, K., and Iwakura, Y. (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173–6177.

    CAS  PubMed  Google Scholar 

  39. Lubberts, E., Joosten, L. A., Oppers, B., et al. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167, 1004–1013.

    CAS  PubMed  Google Scholar 

  40. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., et al. (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50, 650–659.

    Article  CAS  PubMed  Google Scholar 

  41. Lawlor, K. E., Campbell, I. K., Metcalf, D., et al. (2004) Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 101, 11,398–11,403.

    Article  CAS  PubMed  Google Scholar 

  42. Cuzzocrea, S., Mazzon, E., Dugo, L., et al. (2001) Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis. Eur. Cytokine Netw. 12, 568–580.

    CAS  PubMed  Google Scholar 

  43. Johansson, A. C., Hansson, A. S., Nandakumar, K. S., Backlund, J., and Holmdahl, R. (2001) IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J. Immunol. 167, 3505–3512.

    CAS  PubMed  Google Scholar 

  44. Walmsley, M., Katsikis, P. D., Abney, E., et al. (1996) IL-10 inhibits progression of established collagen-induced arthritis. Arthritis Rheum. 39, 495–503.

    Article  CAS  PubMed  Google Scholar 

  45. Mauri, C., Williams, R. O., Walmsley, M., and Feldmann, M. (1996) Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26, 1511–1518.

    Article  CAS  PubMed  Google Scholar 

  46. Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., and Matthys, P. (1997) Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J. Immunol. 158, 5507–5513.

    CAS  PubMed  Google Scholar 

  47. Manoury-Schwartz, B., Chiocchia, G., Bessis, N., et al. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 158, 5501–5506.

    CAS  PubMed  Google Scholar 

  48. Williams, R. O., Williams, D. G., Feldmann, M., and Maini, R. N. (1993) Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin. Exp. Immunol. 92, 323–327.

    Article  CAS  PubMed  Google Scholar 

  49. Boissier, M. C., Chiocchia, G., Bessis, N., et al. (1995) Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol. 25, 1184–1190.

    Article  CAS  PubMed  Google Scholar 

  50. Brennan, F. M., Zachariae, C. O., Chantry, D., et al. (1990) Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur. J. Immunol. 20, 2141–2144.

    Article  CAS  PubMed  Google Scholar 

  51. Alvaro-Garcia, J. M., Zvaifler, N. J., Brown, C. B., Kaushansky, L., and Firestein, G. S. (1991) Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and TNFα. J. Immunol. 146, 3365–3371.

    Google Scholar 

  52. Butler, D. M., Maini, R. N., Feldmann, M., and Brennan, F. M. (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur. Cytokine Netw. 6, 225–230.

    CAS  PubMed  Google Scholar 

  53. Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., and Palladino, M. A. (1992) Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89, 7375–7379.

    Article  CAS  PubMed  Google Scholar 

  54. Williams, R. O., Feldmann, M., and Maini, R. N. (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89, 9784–9788.

    Article  CAS  PubMed  Google Scholar 

  55. Piguet, P. F., Grau, G. E., Vesin, C., Loetscher, H., Gentz, R., and Lesslauer, W. (1992) Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77, 510–514.

    CAS  PubMed  Google Scholar 

  56. Sheehan, K. C., Ruddle, N. H., and Schreiber, R. D. (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142, 3884–3893.

    CAS  PubMed  Google Scholar 

  57. Wooley, P. H., Dutcher, J., Widmer, M. B., and Gillis, S. (1993) Influence of a recombinant human soluble tumour necrosis factor receptor Fc fusion protein on type II collagen-induced arthritis in mice. J. Immunol. 151, 6602–6607.

    CAS  PubMed  Google Scholar 

  58. Williams, R. O., Ghrayeb, J., Feldmann, M., and Maini, R. N. (1995) Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 84, 433–439.

    CAS  PubMed  Google Scholar 

  59. Issekutz, A. C., Meager, A., Otterness, I., and Issekutz, T. B. (1994) The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin. Exp. Immunol. 97, 26–32.

    Article  CAS  PubMed  Google Scholar 

  60. Van den Berg, W. B., Joosten, L. A., Helsen, M., and van de Loo, F. A. (1994) Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95, 237–243.

    Article  PubMed  Google Scholar 

  61. Joosten, L. A. B., Helen, M. M. A., van de Loo, F. A. J., and Van den Berg, W. B. (1996) Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum. 39, 797–809.

    Article  CAS  PubMed  Google Scholar 

  62. Lewthwaite, J., Blake, S., Hardingham, T., et al. (1995) Role of TNFα in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNFα neutralising monoclonal antibodies. Ann. Rheum. Dis. 54, 366–374.

    Article  CAS  PubMed  Google Scholar 

  63. van de Loo, F. A., Joosten, L. A., van Lent, P. L., Arntz, O. J., and Van den Berg, W. B. (1995) Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum. 38, 164–172.

    Article  PubMed  Google Scholar 

  64. Kuiper, S., Joosten, L. A., Bendele, A. M., et al. (1998) Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 10, 690–702.

    Article  CAS  PubMed  Google Scholar 

  65. Geiger, T., Towbin, H., Cosenti-Vargas, A., et al. (1993) Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin. Exp. Rheumatol. 11, 515–522.

    CAS  PubMed  Google Scholar 

  66. Bendele, A., McAbee, T., Sennello, G., Frazier, J., Chlipala, E., and McCabe, D. (1999) Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Arthritis Rheum. 42, 498–506.

    Article  CAS  PubMed  Google Scholar 

  67. Bessis, N., Guery, L., Mantovani, A., et al. (2000) The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur. J. Immunol. 30, 867–875.

    Article  CAS  PubMed  Google Scholar 

  68. Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., et al. (1998) Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41, 2196–2204.

    Article  CAS  PubMed  Google Scholar 

  69. Williams, R. O., Marinova-Mutafchieva, L., Feldmann, M., and Maini, R. N. (2000) Evaluation of TNFα and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNFα/anti-CD4 therapy. J. Immunol. 165, 7240–7245.

    CAS  PubMed  Google Scholar 

  70. Miller, E. J. (1972) Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 11, 4903–4909.

    Article  CAS  PubMed  Google Scholar 

  71. Herbage, D., Bouillet, J., and Bernengo, J. C. (1977) Biochemical and physiochemical characterization of pepsin-solubilized type-II collagen from bovine articular cartilage. Biochem. J. 161, 303–312.

    CAS  PubMed  Google Scholar 

  72. Ratcliffe, A., Doherty, M., Maini, R. N., and Hardingham, T. E. (1988) Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease. Ann. Rheum. Dis. 47, 826–832.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kennedy Institute of Rheumatology Division, Imperial College London, London, UK

    Richard O. Williams

Authors
  1. Richard O. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway

    Mouldy Sioud

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this protocol

Cite this protocol

Williams, R.O. (2007). Collagen-Induced Arthritis in Mice. In: Sioud, M. (eds) Target Discovery and Validation Reviews and Protocols. Methods in Molecular Biology™, vol 361. Humana Press. https://doi.org/10.1385/1-59745-208-4:265

Download citation

  • DOI: https://doi.org/10.1385/1-59745-208-4:265

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-890-4

  • Online ISBN: 978-1-59745-208-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation